Market Research Report - 217000
Triple Analysis: Breast Cancer, Antibodies and Peptides
|Published by||BioSeeker Group AB|
|Published||Content info||5129 Pages|
|Triple Analysis: Breast Cancer, Antibodies and Peptides|
|Published: January 7, 2013||Content info: 5129 Pages||
This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas.